Non-synonymous single-nucleotide variations of the human oxytocin receptor gene and autism spectrum disorders: A case-control study in a Japanese population and functional analysis

Molecular Autism

Volumn 4, Issue 1, 2013, Pages

  Ma, Wen Jie ^a   Hashii, Minako ^a   Munesue, Toshio ^a   Hayashi, Kenshi ^b   Yagi, Kunimasa ^a   Yamagishi, Masakazu ^a   Higashida, Haruhiro ^a,c,d   Yokoyama, Shigeru ^a,c,d  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d MEXT Strategic Research Program for Brain Science (SRPBS)   (Japan)

Author keywords

Autism spectrum disorders; Inositol 1,4,5 trisphosphate; Intracellular free calcium; Oxytocin; Oxytocin receptor; Single nucleotide variation

Indexed keywords

CALCIUM; ENHANCED GREEN FLUORESCENT PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; OXYTOCIN RECEPTOR;

ADOLESCENT; ARTICLE; AUTISM; CASE CONTROL STUDY; CELL STRAIN HEK293; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTERNALIZATION; JAPANESE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOASSAY; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879471590     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/2040-2392-4-22     Document Type: Article

References (54)

1. Oxytocin, vasopressin and sociality. Carter CS, Grippo AJ, Pournajafi-Nazarloo H, Ruscio MG, Porges SW, Prog Brain Res 2008 170 331 336 18655893 (Pubitemid 352010239)
2. Oxytocin, vasopressin, and the neurogenetics of sociality. Donaldson ZR, Young LJ, Science 2008 322 900 904 10.1126/science.1158668 18988842
3. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. Neumann ID, J Neuroendocrinol 2008 20 858 865 10.1111/j.1365-2826.2008.01726.x 18601710 (Pubitemid 351858739)
4. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? McGregor IS, Callaghan PD, Hunt GE, Br J Pharmacol 2008 154 358 368 18475254 (Pubitemid 351670596)
5. Dopaminergic-neuropeptide interactions in the social brain. Skuse DH, Gallagher L, Trends Cogn Sci 2009 13 27 35 10.1016/j.tics.2008.09.007 19084465
6. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M, Nat Rev Neurosci 2011 12 524 538 10.1038/nrn3044 21852800
7. Dendritic peptide release and peptide-dependent behaviours. Ludwig M, Leng G, Nat Rev Neurosci 2006 7 126 136 10.1038/nrn1845 16429122 (Pubitemid 43151599)
8. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Knobloch HS, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH, Osten P, Schwarz MK, Seeburg PH, Stoop R, Grinevich V, Neuron 2012 73 553 566 10.1016/j.neuron.2011.11.030 22325206
9. Oxytocin receptors: ligand binding, signalling and cholesterol dependence. Gimpl G, Reitz J, Brauer S, Trossen C, Prog Brain Res 2008 170 193 204 18655883 (Pubitemid 352010230)
10. Dynamic interaction of human vasopressin/oxytocin receptor subtypes with G protein-coupled receptor kinases and protein kinase C after agonist stimulation. Berrada K, Plesnicher CL, Luo X, Thibonnier M, J Biol Chem 2000 275 27229 27237 10858434
11. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG, J Biol Chem 2001 276 19452 19460 10.1074/jbc.M101450200 11279203
12. Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. Hasbi A, Devost D, Laporte SA, Zingg HH, Mol Endocrinol 2004 18 1277 1286 10.1210/me.2003-0440 14976224 (Pubitemid 38591291)
13. Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 "short cycle" Conti F, Sertic S, Reversi A, Chini B, Am J Physiol Endocrinol Metab 2009 29 532 E542
14. Social amnesia in mice lacking the oxytocin gene. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT, Nat Genet 2000 25 284 288 10.1038/77040 10888874 (Pubitemid 30437313)
15. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K, Proc Natl Acad Sci USA 2005 102 16096 160101 10.1073/pnas.0505312102 16249339 (Pubitemid 41552873)
16. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, Capurro V, Finardi A, Donzelli A, Pattini L, Rubino T, Parolaro D, Nishimori K, Parenti M, Chini B, Biol Psychiatry 2010 69 875 882
17. CD38 is critical for social behaviour by regulating oxytocin secretion. Jin D, Liu HX, Hirai H, Torashima T, Nagai T, Lopatina O, Shnayder NA, Yamada K, Noda M, Seike T, Fujita K, Takasawa S, Yokoyama S, Koizumi K, Shiraishi Y, Tanaka S, Hashii M, Yoshihara T, Higashida K, Islam MS, Yamada N, Hayashi K, Noguchi N, Kato I, Okamoto H, Matsushima A, Salmina A, Munesue T, Shimizu N, Mochida S, et al. Nature 2007 446 41 45 10.1038/nature05526 17287729 (Pubitemid 46348037)
18. Locomotor activity, ultrasonic vocalization and oxytocin levels in infant CD38 knockout mice. Liu HX, Lopatina O, Higashida C, Tsuji T, Kato I, Takasawa S, Okamoto H, Yokoyama S, Higashida H, Neurosci Lett 2008 448 67 70 10.1016/j.neulet.2008.09.084 18926879
19. Oxytocin-induced elevation of ADP-ribosyl cyclase activity, cyclic ADP-ribose or Ca§ssup§2+§esup§ concentrations is involved in autoregulation of oxytocin secretion in the hypothalamus and posterior pituitary in male mice. Lopatina O, Liu HX, Amina S, Hashii M, Higashida H, Neuropharmacology 2010 58 50 55 10.1016/j.neuropharm.2009.06.012 19540855
20. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Graustella AJ, MacLeod C, Horm Behav 2012 61 410 418 10.1016/j.yhbeh.2012.01.002 22265852
21. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, Lintas C, Abramson RK, Wright HH, Ellis P, Langford CF, Worley G, Delong GR, Murphy SK, Cuccaro ML, Persico A, Pericak-Vance MA, BMC Med 2009 7 62 10.1186/1741-7015-7-62 19845972
22. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Wu S, Jia M, Ruan Y, Liu J, Guo Y, Shuang M, Gong X, Zhang Y, Yang X, Zhang D, Biol Psychiatry 2005 58 74 77 10.1016/j.biopsych. 2005.03.013 15992526 (Pubitemid 40909939)
23. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Jacob S, Brune CW, Carter CS, Leventhal BL, Lord C, Cook EHJ, Neurosci Lett 2007 417 6 9 10.1016/j.neulet.2007.02.001 17383819 (Pubitemid 46517832)
24. Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition. Lerer E, Levi S, Salomon S, Darvasi A, Yirmiya N, Ebstein RP, Mol Psychiatry 2008 13 980 988 10.1038/sj.mp.4002087 17893705
25. Genes controlling affiliative behavior as candidate genes for autism. Yrigollen CM, Han SS, Kochetkova A, Babitz T, Chang JT, Volkmar FR, Leckman JF, Grigorenko EL, Biol Psychiatry 2008 63 911 916 10.1016/j.biopsych.2007.11.015 18207134
26. Arginine vasopressin and oxytocin modulate human social behavior. Ebstein RP, Israel S, Lerer E, Uzefovsky F, Shalev I, Gritsenko I, Riebold M, Salomon S, Yirmiya N, Ann NY Acad Sci 2009 1167 87 102 10.1111/j.1749-6632.2009.04541.x 19580556
27. Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. Liu X, Kawamura Y, Shimada T, Otowa T, Koishi S, Sugiyama T, Nishida H, Hashimoto O, Nakagami R, Tochigi M, Umekage T, Kano Y, Miyagawa T, Kato N, Tokunaga K, Sasaki T, J Hum Genet 2010 55 137 141 10.1038/jhg.2009.140 20094064
28. Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. Wermter AK, Kamp-Becker I, Hesse P, Schulte-Körne G, Strauch K, Remschmidt H, Am J Med Genet B Neuropsychiatr Genet 2010 153B 629 639 19777562
29. Neural mechanisms of social risk for psychiatric disorders. Meyer-Lindenberg A, Tost H, Nat Neurosci 2012 15 663 668 10.1038/nn.3083 22504349
30. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. den Dunnen JT, Antonarakis SE, Hum Mut 2000 15 7 12 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N 10612815 (Pubitemid 30036162)
31. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Munesue T, Yokoyama S, Nakamura K, Anitha A, Yamada K, Hayashi K, Asaka T, Liu HX, Jin D, Koizumi K, Islam MS, Huang JJ, Ma WJ, Kim UH, Kim SJ, Park K, Kim D, Kikuchi M, Ono Y, Nakatani H, Suda S, Miyachi T, Hirai H, Salmina A, Pichugina YA, Soumarokov AA, Takei N, Mori N, Tsujii M, Sugiyama T, et al. Neurosci Res 2010 67 181 191 10.1016/j.neures.2010.03.004 20435366
32. The Asperger Syndrome (and high-functioning autism) Diagnostic Interview (ASDI): a preliminary study of a new structured clinical interview. Gillberg C, Gillberg C, Rastam M, Wentz E, Autism 2001 5 57 66 10.1177/1362361301005001006 11708390 (Pubitemid 32266099)
33. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Lord C, Rutter M, Le Couteur A, J Autism Dev Disord 1994 24 659 685 10.1007/BF02172145 7814313 (Pubitemid 24309810)
34. Autism Society Japan, Pervasive Developmental Disorders Autism Society Japan Rating Scale (PARS) Tokyo 2006
35. The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. Wing L, Leekam SR, Libby SJ, Gould J, Larcombe M, J Child Psychol Psychiat 2002 43 307 325 10.1111/1469-7610.00023 11944874 (Pubitemid 36939220)
36. The reliability and validity of the Tokyo Autistic Behavior Scale. Kurita H, Miyake Y, Psychiat Clin Neurosci 1990 44 25 32 10.1111/j.1440-1819.1990. tb00438.x (Pubitemid 20236593)
37. Site-directed mutagenesis using a single mutagenic oligonucleotide and DpnI digestion of template DNA. Shenoy AR, Visweswariah SS, Anal Biochem 2003 319 335 336 10.1016/S0003-2697(03)00286-0 12871732 (Pubitemid 36842747)
38. Intracellular calcium elevation induced by extracellular application of cyclic-ADP-ribose or oxytocin is temperature-sensitive in rodent NG108-15 neuronal cells with or without exogenous expression of human oxytocin receptors. Amina S, Hashii M, Ma WJ, Yokoyama S, Lopatina O, Liu HX, Islam MS, Higashida H, J Neuroendocrinol 2010 22 460 466 10.1111/j.1365-2826.2010.01978.x 20163520
39. cADP-ribose potentiates cytosolic Ca§ssup§2+§esup§ elevation and Ca§ssup§2+§esup§ entry via L-type voltage-activated Ca§ssup§2+§esup§ channels in NG108-15 neuronal cells. Hashii M, Minabe Y, Higashida H, Biochem J 2000 345 207 215 10.1042/0264-6021:3450207 10620496 (Pubitemid 30077159)
40. dbSNP Short Genetic Variations. [ http://www.ncbi.nlm.nih.gov/SNP/ ]
41. Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies. Tansey KE, Brookes KJ, Hill MJ, Cochrane LE, Gill M, Skuse D, Correia C, Vicente A, Kent L, Gallagher L, Anney RJL, Neurosci Lett 2010 474 163 167 10.1016/j.neulet.2010.03.035 20303388
42. Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder. Campbell DB, Datta D, Jones ST, Batey Lee E, Sutcliffe JS, Hammock EA, Levitt P, J Neurodev Disord 2011 3 101 112 10.1007/s11689-010-9071-2 21484202
43. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Cirulli ET, Goldstein DB, Nat Rev Genet 2010 11 415 425 10.1038/nrg2779 20479773
44. Genetics of autism spectrum disorders. Geschwind DH, Trends Cogn Sci 2011 15 409 416 10.1016/j.tics.2011.07.003 21855394
45. The conundrums of understanding genetic risks for autism spectrum disorders. State MW, Levitt P, Nat Neurosci 2011 14 1499 1506 10.1038/nn.2924 22037497
46. Common and rare variants in multifactorial susceptibility to common diseases. Bodmer W, Bonilla C, Nat Genet 2008 40 695 701 10.1038/ng.f.136 18509313 (Pubitemid 351748875)
47. Common vs. rare allele hypotheses for complex diseases. Schork NJ, Murray SS, Frazer KA, Topol EJ, Curr Opin Genet Dev 2009 19 212 219 10.1016/j.gde.2009.04.010 19481926
48. Phosphorylation of the V2 vasopressin receptor. Innamorati G, Sadeghi H, Eberle AN, Birnbaumer M, J Biol Chem 1997 272 2486 2492 10.1074/jbc.272.4.2486 8999963 (Pubitemid 27058540)
49. The proximal portion of the COOH terminus of the oxytocin receptor is required for coupling to G§ssub§q§esub§, but not G§ssub§i§esub§: independent mechanisms for elevating intracellular calcium concentrations from intracellular stores. Hoare S, Copland JA, Strakova Z, Ives K, Jeng YJ, Hellmich MR, Soloff MS, J Biol Chem 1999 274 28682 28689 10.1074/jbc.274.40.28682 10497238 (Pubitemid 29473001)
50. Molecular mechanisms of autism: a possible role for Ca§ssup§ 2+§esup§ signaling. Krey JF, Dolmetsch RE, Curr Opin Neurobiol 2007 17 112 119 10.1016/j.conb.2007.01.010 17275285 (Pubitemid 46227984)
51. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. Ninan I, J Neurochem 2011 119 324 331 10.1111/j.1471-4159.2011.07430.x 21848811
52. Pharmacogenetics, pharmacogenomics, and individualized medicine. Ma Q, Lu AYH, Pharmacol Rev 2011 68 437 459
53. Pharmacogenetics. Relling MV, Giacomini KM, Goodman & Gilman's The Pharmacological Basis of Therapeutics New York: McGraw-Hill, Brunton LL, 12 2011 145 168 23822531
54. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ, Psychoneuroendocrinology 2011 36 1114 1126 10.1016/j.psyneuen. 2011.02.015 21429671